⌘K

Home/Filings/4/0001179110-20-002141

4//SEC Filing

BRADY ANN 4

Accession 0001179110-20-002141

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:05 PM ET

Size

4.4 KB

Accession

0001179110-20-002141

Insider Transaction Report

Form 4

Period: 2020-02-20

Theravance Biopharma, Inc.TBPH

President, TBIL

Transactions

Tax Payment
Ordinary Shares
2020-02-20$25.90/sh−5,948$154,053→ 105,163 total

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001767974

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 7:05 PM ET
Size: 4.4 KB

View on SEC.gov